Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

2021 ◽  
Author(s):  
Niels Jongs ◽  
Tom Greene ◽  
Glenn M Chertow ◽  
John J V McMurray ◽  
Anna Maria Langkilde ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Urinary Albumin Excretion ◽  
Urinary Albumin ◽  
Albumin Excretion

Urinary albumin excretion and chronic kidney disease in children with vesicoureteral reflux

2017 ◽  
Vol 13 (6) ◽  
pp. 592.e1-592.e7 ◽  
Author(s):  
Romaine de Sépibus ◽  
François Cachat ◽  
Blaise J. Meyrat ◽  
Gezim Dushi ◽  
Ariane Boubaker ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Vesicoureteral Reflux ◽  
Urinary Albumin Excretion ◽  
Urinary Albumin ◽  
Albumin Excretion

scholarly journals Association Between Urinary Albumin Excretion and Serum Dehydroepiandrosterone Sulfate Concentrations in Women With Type 2 Diabetes

Diabetes Care ◽  
2007 ◽  
Vol 30 (7) ◽  
pp. 1886-1888 ◽  
Author(s):  
M. Fukui ◽  
H. Ose ◽  
I. Nakayama ◽  
H. Hosoda ◽  
M. Asano ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Urinary Albumin Excretion ◽  
Dehydroepiandrosterone Sulfate ◽  
Urinary Albumin ◽  
Albumin Excretion

scholarly journals Administration of RAS Inhibitor before the Onset of Diabetic Nephropathy Counteracts the Adverse Effect of Chronic Hyperglycemia and Reduces the Augmentation of Urinary Albumin Excretion: A Retrospective Clinical Study

2018 ◽  
Vol 2018 ◽  
pp. 1-5
Author(s):  
Hidenori Hirukawa ◽  
Shinji Kamei ◽  
Tomohiko Kimura ◽  
Atsushi Obata ◽  
Kenji Kohara ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Renal Function ◽  
Diabetic Nephropathy ◽  
Urinary Albumin Excretion ◽  
Urinary Albumin ◽  
Albumin Excretion ◽  
Chronic Hyperglycemia ◽  
Retrospective Clinical Study ◽  
Japanese Subjects

It is very important to explore how we can reduce urinary albumin excretion which is an independent risk factor for ischemic heart disease. In this study, we retrospectively evaluated the effects of RAS inhibitor therapy on diabetic nephropathy in Japanese subjects whose urinary albumin levels were within normal range. We enrolled 100 subjects with type 2 diabetes who did not take any renin-angiotensin system (RAS) inhibitor. We defined the subjects taking RAS inhibitor for more than 3 years as RAS inhibitor group. RAS inhibitor exerted protective effect on the progression of urinary albumin excretion in subjects with type 2 diabetes without diabetic nephropathy. In addition, RAS inhibitor exerted more protective effects on renal function especially in subjects with poor glycemic control. In conclusion, RAS inhibitor could protect renal function against the deleterious effect of chronic hyperglycemia in Japanese subjects with type 2 diabetes even before the onset of diabetic nephropathy.

scholarly journals FP152EFFECT OF BARDOXOLONE METHYL TREATMENT ON URINARY ALBUMIN IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE - POST-HOC ANALYSIS FROM BEAM AND BEACON

2018 ◽  
Vol 33 (suppl_1) ◽  
pp. i27-i27
Author(s):  
Peter Rossing ◽  
Geoffrey Block ◽  
Glenn Chertow ◽  
Melanie Chin ◽  
Angie Goldsberry ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Urinary Albumin ◽  
Post Hoc Analysis ◽  
Post Hoc
Sign in / Sign up

Export Citation Format

Share Document